Stephens Consulting, LLC Anixa Biosciences Inc Transaction History
Stephens Consulting, LLC
- $400 Billion
- Q4 2024
A detailed history of Stephens Consulting, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 1,000 shares of ANIX stock, worth $2,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$2,920% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
62Shares Held
5.73MCall Options Held
7.1KPut Options Held
26.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.07 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$1.96 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.82 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.56 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.37 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $89.5M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...